A new report from the Centers for Disease Control and Prevention found that fear was responsible for a number of side effects of the Johnson & Johnson vaccine rather than the shot itself.
From April 7 to April 9, the CDC received reports of “clusters of anxiety-related events” after patients received the J&J Vaccine, including hyperventilation, low blood pressure, headache, difficulty breathing, drowsiness, nausea, and fainting, including at five mass vaccination sites.
At four of these locations, administrators temporarily stopped offering coronavirus vaccines due to the high relative frequency of fainting spells – 8.2 people per 100,000, according to the CDC. For comparison: 0.05 people per 100,000 Passed out after receiving an influenza vaccine.
After interviewing 64 patients (out of 8,624) who experienced these symptoms, the CDC concluded that none of the cases met the definition of serious adverse effects and that the majority were resolved within 15 minutes. The researchers attributed the symptoms to anxiety rather than J&J discrepancies Vaccine and its Pfizer and Moderna counterparts.
In fact, the main difference between Johnson & Johnson – also known as the Janssen vaccine – and the other vaccines is that it only requires a dose that the CDC suspected could be causing increased anxiety in the area.
“Because the Janssen COVID-19 vaccine is given as a single dose, this vaccine may be a more attractive option for those with needle aversion,” the report said. “Therefore, it is possible that some people applying for a Janssen COVID-19 vaccination may be more predisposed to fear-related events after vaccination.”
Fainting spells were mostly concentrated in the youngest eligible group – those 18 to 29 year olds. The report found that is to be expected given that teenagers have the highest rates of dizziness and fainting after other vaccines.
The CDC recommended vaccine administrators observe patients for at least 15 minutes after the injection to monitor for any anxiety-related effects.
The side effects described in the study are unrelated to the 17 cases in which patients developed blood clots, resulting in a nationwide hiatus from the J&J Use of the vaccine in mid-April. The CDC found these cases to be extremely rare and worked with the FDA to lift the 10-day break. The vaccine now warns women under 50 of the risk of developing a blood clot.
Biden restricts travel from India as the coronavirus rises
The US vaccination campaign recently reached a milestone with over 100 million people fully vaccinated, nearly doubling since late March. And while the number of cases in the US is falling, the daily average is around According to the New York Times, global virus cases last week hit a new high since mid-October.
Much of the surge is being driven by a second wave in India, which now accounts for over 40 percent of the world’s new cases, according to the Times. As Jen Kirby and Umair Irfam reported for Vox, Indian hospitals are in dire need of oxygen, ventilators, beds and vaccines, with less than 2 percent of the country being fully vaccinated.
Biden’s government has promised to ship supplies, including raw materials for vaccine production, despite some experts calling for coronavirus vaccine intellectual property rules to be lifted so that India, a world leader, can catch up. The government is considering this option, but in the meantime, the US will impose restrictions on travel from India starting Tuesday.
In a statement to CNN, White House press secretary Jen Psaki said the high number of cases in India, as well as possible new variants, had fueled policy development. Foreign nationals who have been to India in the past 14 days are temporarily banned from entering the United States. The rule does not apply to American citizens, permanent residents, and humanitarian workers.